Literature DB >> 2474349

Divalent cation dependence of the inhibition by phenothiazines of mediator release from mast cells.

P T Peachell1, F L Pearce.   

Abstract

1. The divalent cations calcium, strontium and barium--and in that order of decreasing effectiveness--were capable of supporting the stimulated release of histamine from rat peritoneal mast cells (RPMC). 2. The responsiveness of mast cells to stimulation in the presence of divalent cations was, in general, markedly enhanced when the cells were first depleted of their intracellular calcium stores. 3. The putative calmodulin antagonists, chlorpromazine, promethazine, thioridazine (phenothiazines) and W-7 (a naphthalene sulphonamide) all inhibited histamine release in the presence of divalent cations in both untreated cells and in RPMC depleted of their intracellular calcium. 4. Histamine release induced by antigen, compound 48/80 and ionophore A23187 was inhibited by this class of compounds most effectively in the presence of extracellular barium, less so in the presence of strontium and least so in calcium-containing media. 5. In the experimental situation where the extracellular calcium concentration was reduced (less than 1 mM), the phenothiazines inhibited the stimulated release of histamine more effectively. 6. In toto, these results suggest that strontium and barium, as well as calcium, can support histamine release from RPMC by directly interacting with an intracellular divalent cation-binding site that may be calmodulin. As a consequence, one mechanism by which the phenothiazines and W-7 may modulate the secretory response could reflect an antagonism of a divalent cation interaction at that same site, although other additional potential sites of inhibitory action are indicated, dependent on the stimulus employed for secretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474349      PMCID: PMC1854540          DOI: 10.1111/j.1476-5381.1989.tb11984.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  A method for the fluorometric assay of histamine in tissues.

Authors:  P A SHORE; A BURKHALTER; V H COHN
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

Review 2.  Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.

Authors:  N Chand; J L Perhach; W Diamantis; R D Sofia
Journal:  Agents Actions       Date:  1986-03

3.  Effect of calmodulin inhibitors on histamine secretion from mast cells.

Authors:  P T Peachell; F L Pearce
Journal:  Agents Actions       Date:  1985-03

4.  Calmodulin in mast cells and its role in histamine secretion.

Authors:  N Chakravarty; E H Nielsen
Journal:  Agents Actions       Date:  1985-04

5.  Sequential events in calmodulin on binding with calcium and interaction with target enzymes.

Authors:  J A Cox
Journal:  Fed Proc       Date:  1984-12

6.  Effects of calmodulin antagonists on tension and cellular calcium content in depolarized vascular and intestinal smooth muscles.

Authors:  H Karaki; K Murakami; H Nakagawa; H Ozaki; N Urakawa
Journal:  Br J Pharmacol       Date:  1982-12       Impact factor: 8.739

Review 7.  Calmodulin: its potential role in cell proliferation and heavy metal toxicity.

Authors:  W Y Cheung
Journal:  Fed Proc       Date:  1984-12

8.  N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide(W-7), a calmodulin antagonist, also inhibits phospholipid-sensitive calcium-dependent protein kinase.

Authors:  R C Schatzman; R L Raynor; J F Kuo
Journal:  Biochim Biophys Acta       Date:  1983-01-04

9.  Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell.

Authors:  J R White; T Ishizaka; K Ishizaka; R Sha'afi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

10.  Synergistic action of protein kinase C and calcium for histamine release from rat peritoneal mast cells.

Authors:  Y Katakami; K Kaibuchi; M Sawamura; Y Takai; Y Nishizuka
Journal:  Biochem Biophys Res Commun       Date:  1984-06-15       Impact factor: 3.575

View more
  1 in total

1.  Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome.

Authors:  Anthony Clemons; Magdalini Vasiadi; Duraisamy Kempuraj; Taxiarchis Kourelis; Gregory Vandoros; Theoharis C Theoharides
Journal:  J Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.